Drug Type Gene therapy |
Synonyms- |
Target |
Mechanism Nav1.1 modulators(Sodium channel protein type I alpha subunit modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epilepsies, Myoclonic | Preclinical | US | 20 Aug 2024 | |
Epilepsies, Myoclonic | Preclinical | US | 20 Aug 2024 |